Fig. 3
From: Expert consensus on the management of systemic sclerosis-associated interstitial lung disease
Consensus recommendations for SSc-ILD treatment criteria. dcSSc diffuse cutaneous SSc, DLCO diffusing capacity of the lungs for carbon monoxide, FVC forced vital capacity, HRCT high-resolution computed tomography, ILD interstitial lung disease, LLN lower limit of normal, PFT pulmonary function test, RNP ribonucleoprotein, SD standard deviation, SpO2 peripheral capillary oxygen saturation, SSc systemic sclerosis, Topo topoisomerase